|
HS Code |
952815 |
| name | Ronidazole |
| chemical_formula | C6H8N4O2 |
| molecular_weight | 168.15 g/mol |
| drug_class | Nitroimidazole antimicrobial |
| mechanism_of_action | Inhibits nucleic acid synthesis in protozoa and bacteria |
| appearance | White to off-white crystalline powder |
| route_of_administration | Oral |
| primary_use | Treatment of protozoal and anaerobic bacterial infections |
| veterinary_use | Commonly used in pigeons, cats, and other animals |
| solubility | Slightly soluble in water |
| cas_number | 7681-76-7 |
| storage_conditions | Store in a cool, dry place away from light |
As an accredited Ronidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ronidazole is packaged in a sealed, amber glass bottle containing 100 grams of off-white powder, labeled with handling and storage instructions. |
| Shipping | Ronidazole is shipped in secure, tightly sealed containers to prevent contamination and moisture exposure. Packaging complies with international chemical safety standards, including proper labeling and documentation. The shipment is handled by certified carriers and stored at controlled room temperature. Delivery ensures product integrity and traceability throughout transit, with safety data sheets included. |
| Storage | Ronidazole should be stored in a tightly closed container at room temperature, ideally between 15°C and 30°C (59°F to 86°F). It should be kept in a dry, well-ventilated area away from light, moisture, and incompatible substances. Proper storage ensures stability and safety, preventing degradation or contamination of the chemical. Keep out of reach of children and unauthorized personnel. |
Applications of Ronidazole in Industrial ManufacturingRonidazole serves as a key intermediate for several specialized sectors requiring high-purity raw materials. Our production strictly controls process quality and traceability to meet the distinct needs of veterinary pharmaceutical, aquaculture, avian feed, and companion animal medicine manufacturers. Below, we detail targeted applications and integration insights for each downstream segment. 1. Veterinary Pharmaceutical ProductionVeterinary pharmaceutical companies use Ronidazole as an active pharmaceutical ingredient (API) in antiprotozoal medications for livestock, particularly for the prevention and treatment of histomoniasis (blackhead disease) in turkeys and protozoal infections in pigs. We supply Ronidazole in specified grades to ensure compliant formulation, maximum bioavailability, and compatibility with common excipients in tablet and water-soluble powder forms. Our process enables precise control over particle size and purity, critical for manufacturers aiming for consistent batch quality and registration with regulatory agencies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Fish and Shrimp Aquaculture MedicationsAquaculture health product manufacturers employ Ronidazole in medicated feeds and water treatments targeting protozoal and myxosporean infections in ornamental and food fish, as well as shrimp. The strict regulatory environment for medicated aquafeeds demands reliable traceability and safe residual levels in handled seafood. We offer trace-metals controlled grades, tailored moisture specifications, and validated absence of nitroimidazole analog contaminants to support finished feed compliance and safety monitoring. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Pigeon and Racing Bird MedicationsSpecialist avian medicine producers depend on Ronidazole as a highly effective trichomoniasis treatment for racing pigeons and exotic aviary birds. Purity, stability, and residue control are essential due to strict competitive regulations and the risk of doping violations. We provide full batch traceability, heat-stable grades, and options for custom micronization to support manufacturers in formulating individual-dosing sachets, feed premixes, and oral drops in compliance with racing club standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Companion Animal Antiprotozoal PreparationsRonidazole is incorporated by animal pharmaceutical companies into custom formulations for treating protozoal infections, such as giardiasis and trichomoniasis, in cats and small companion animals where metronidazole resistance is a concern. Pet pharmaceutical manufacturers require high assay, impurity profile documentation, and GMP batch validation to ensure safety and precise dose delivery, especially for small animal weight ranges. The process includes direct blending or granulation, followed by analytical verification for compliance with target pharmaceutical application. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Ronidazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Ronidazole represents a key member of the nitroimidazole class, widely recognized in veterinary medicine. From the vantage point of a chemical manufacturer, this compound holds a unique profile, both in chemistry and in its applications. Our production floor is no stranger to the demands for pure, consistent Ronidazole—delivered in the form, quality, and scale professionals expect.
The molecular structure of Ronidazole, C6H9N3O3, sets it apart from other antimicrobials. Each batch rolls out of the reactor meeting stringent purity criteria. Most markets look for Ronidazole at a minimum of 98% assay, confirmed by HPLC, with a white crystalline powder appearance. Particle size and flow properties are tightly controlled, allowing for easy handling, feeding, and formulation. By opting for these specifications, we minimize headache for downstream processors, whether they are compounding oral suspensions for cats or creating tablets for poultry.
As a manufacturer, day-to-day experience with Ronidazole involves careful calibration of synthesis routes, quality checks at every stage, and rapid turnaround. Compared to other imidazoles, the chemistry of Ronidazole involves distinct steps that influence yield and quality. For instance, chlorination and nitration processes often require close monitoring. It's not just about reaching the targeted purity; trace impurities must sit well below allowable thresholds, or you risk regulatory setbacks and poor product performance.
What often goes unspoken outside manufacturing circles is the challenge in scaling production. Unlike supplements or simple feed additives, Ronidazole’s synthesis brings together several sensitive raw materials. On the line, operators face hazards unique to nitro compounds. Dust control isn't just good housekeeping—it shields workers from irritant exposure and keeps the active material from contamination. We invest in negative pressure rooms, closed-system reactors, and continual worker training to meet evolving safety standards. These controls become especially vital with every shipment that leaves our loading dock—managing both physical and legal risks attached to the product.
Every veterinarian, feed miller, or pet owner relies on Ronidazole's predictable performance. Animals with protozoal infections—like Trichomonas gallinae in pigeons or Tritrichomonas foetus in cats—depend on precise dosing. Subpar batches lead to subtherapeutic exposure. Not enough active ingredient means infections persist, resistance can develop, and animal welfare declines. Overstrength batches risk overdosing and adverse effects.
Manufacturers anchor themselves in these realities. Our customers notify us immediately if they ever find variations; the feedback loop runs in both directions. Quality assurance does not stay confined to the production lot. Every pack that makes its way into the hands of a formulator should match not just the certificate of analysis, but also real-world dosing experience. This explains why repeatability, not just purity, drives manufacturing decisions.
In practice, Ronidazole finds its spot in the arsenal against protozoal diseases, especially in birds and companion animals. The use case often dictates the formulation—poultry and pigeons see the powder in their water or feed, while small pets receive capsules or suspensions. We built our production around the requirements we hear most: good flow, ease of wetting, and stability. Manufacturers further down the supply chain tend to appreciate these features, reducing formulation headache and ensuring even distribution in low-dose applications.
One clear distinction surfaces when compared to metronidazole and other older nitroimidazoles. Ronidazole typically achieves better results in cases resistant to metronidazole. We receive feedback from veterinarians and end-users who notice the shorter treatment windows and fewer relapses. Yet, Ronidazole needs care—it must not be used haphazardly or outside established dosing guidelines, as side effects like neurotoxicity appear at elevated doses.
Manufacturing practices directly influence how easily the product dissolves, its shelf stability, and susceptibility to photodegradation. End-users value consistent wetting and dispersibility. We learned from experience how processing conditions during synthesis and drying impact these properties. Several years ago, one batch passed all lab tests but clumped during compounding—teachable moments like these shaped refinements in our granulation and drying steps.
Clinical performance forms only part of the comparison. From the view in the factory, differences with other drugs also stem from the production side. Metronidazole, for example, flows out of many suppliers due to a more established production route and laxer regulatory control in some countries. Ronidazole faces closer scrutiny in every jurisdiction, which translates into extra testing, longer paperwork cycles, and a need for advanced documentation.
Every new market we enter brings local requirements—residue limits, packaging needs, and sometimes requests for non-standard grades. The adaptability of our process allows us to fine-tune particle size or residual solvents, so products reach new customers without compromising our standards.
On the end-user side, Ronidazole remains the go-to for infections proven resistant to older imidazoles. While the literature usually focuses on Trichomonas species, field reports point to off-label investigations in reptiles and other birds. Our discussions with researchers echo this trend; more labs try Ronidazole as a last resort, driving demand for smaller, custom lots. We make adjustments in minimum order quantities, packaging sizes, and even labeling, responding to feedback from international research teams and veterinary hospitals.
Maintaining Ronidazole’s stability comes down to attention during packaging and logistics. The active still degrades when left long in damp, hot climates. We adopted desiccant-lined drums and foil pouches after reports of caking in tropical shipments. Not every manufacturer goes that extra mile, but repeat business and fewer complaints confirm the value. Customers rely on each package retaining full potency until application; direct-from-manufacturer shipping shortens supply chains and reduces the chance of repackaging failures.
We learned that minor failures in packaging integrity or labeling missteps quickly ripple out. One mislabeled drum can sidetrack a multi-ton shipment, affect hundreds of animals, and put compliance under the spotlight. Care at the packing line never feels like wasted time.
Since entering international markets, we noticed that regulatory expectations and practitioner habits influence how Ronidazole is received across countries. In some regions, authorities enforce mandatory release tests for antibiotic and antiparasitic substances in feeds. Transport documentation, origin certification, and chain-of-custody evidence protect both user and manufacturer. We answer these needs with batch-tracking, tamper-proof seals, and whenever called for, on-site audits by buyers.
Veterinary clinics sometimes need smaller pack sizes, tailored to specific animal populations. University labs, by contrast, may request analytical standards and reference material. We do not just scale production up and down; we adapt sampling and documentation processes to support end-user requirements.
The nature of Ronidazole production exposes the business to changing regulatory pressures. Some countries update animal drug schedules, restricting sales or raising the paperwork burden for manufacturers. Compliance requires strong relationships with certifying bodies, regular staff updates, and a willingness to provide documentation ahead of regulations—not just meet minimum checklists. Five years ago, residue-control regulations tightened without much warning. Because our team already had validated analytical methods, we maintained supply where other companies paused distribution while racing to catch up.
We hold that comprehensive stability and impurity data belong in the registration dossier, not tucked away in a folder. Our on-site quality labs run ongoing stability studies, feeding data back into shelf-life projections. Such vigilance may not show up immediately in quarterly reports, but it secures licenses, boosts customer trust, and shrinks liability down the line.
Beyond simple manufacturing, innovation in Ronidazole stems from working closely with veterinary researchers and formulators. A few years back, we supported a project reducing flavor bitterness in feline suspensions by tweaking excipient compatibility—directly responding to animal owner complaints. Likewise, by partnering with field veterinarians, we identified optimal dosing regimens for canaries, avoiding both underdosing and toxicity.
These partnerships feed back into our own production: feedback identifies which physical properties matter most to formulators, whether it's non-dusting powder or improved dispersibility. We continually test upgrades—coarser or finer grades, improved moisture barriers, additives that prevent cake formation. As Ronidazole’s use spreads, expectations for non-standard grades rise. Our research pipeline thus runs in both directions: from academic labs back to the factory, refining synthesis and shaping future batches.
Ronidazole holds a distinct profile compared to other veterinary antiparasitics. For resistant cases, Ronidazole’s effectiveness provides relief where alternatives might fail. Metronidazole, while still popular, falls short in many chronic or non-responsive cases. Other options, like dimetridazole, now face tighter bans and regulatory headwinds, leaving Ronidazole as the mainstay—especially in the racing pigeon and aviculture world.
Quality control demands increase as resistance becomes a talking point worldwide. Regulators and buyers want robust impurity profiles, clear records of manufacturing sources, and traceable movement through the supply chain. Direct-from-manufacturer supply answers these expectations with fewer hands in the chain, shorter dwell times, and transparency that meets traceability demands.
Our experience after years in the industry tells us that working directly with manufacturers yields results—especially when tight feedback loops and process controls steer decision-making. We see the full picture, from early synthesis through to the last bag being loaded for shipment.
Lean communications let field data reach chemists and plant operators without getting diluted by layers of distributors or resellers. When a vet clinic calls with a question, the answer doesn’t drift through a chain of uncertain sources. Instead, we reach back through our records, checking lot numbers, instrument readouts, and by-operator logs.
Direct customer support also means flexibility in documentation, technical support, and responsiveness to quality concerns. Trends suggest increasing crossover between research and field use, with Ronidazole moving from avian practice toward more companion animal uses. We stay tuned by updating customers on formulation suitability, impurity trends, shipping logistics, and even packaging modifications—long before issues hit social media or the regulatory desk.
Every industry faces growing public scrutiny, and Ronidazole production is not immune. Our sustainability plan tracks resource use, waste minimization, and solvent recycling rates. Staff training, regular safety reviews, and transparent environmental performance reporting address modern stakeholder demands. The shelf life of Ronidazole extends in ideal climate and packaging, meaning less waste at the last mile—a difference that only materializes with smart manufacturing and logistics.
We invite oversight: welcoming audits from buyers, regulators, and certifiers shows a willingness to let facts and evidence build trust. Our policies do not stop at the factory gate—education for transporters, wholesalers, and animal handlers follows up each batch.
The long-term clients choose manufacturers who back up claims with documentation and honest feedback when something’s amiss. We do not expect perfection; we expect transparency and improvement. For Ronidazole, regular review cycles, customer interviews, and joint problem-solving sessions set us apart. As resistance profiles shift or regulatory frameworks evolve, we invest in keeping pace—not just for business, but for public and animal health.
We learn from every returned drum, every formulation hiccup, every customer request for a faster certificate or new particle size. The cumulative learning goes back into the next batch, ensuring every kilogram serves its purpose.
Ronidazole, seen through the eyes of its producer, is not just a chemical. It is the sum of chemistry, process control, decades of regulatory dialogue, field feedback, and a commitment to solving practical challenges. Our perspective moves beyond the label—shaped by hands-on work with synthesis, formulation, packaging, and customer concern. Differences from other antimicrobials are grounded in both how the molecule acts and the realities of bringing it to market legally and reliably.
As use cases broaden, from classic avian infections to new species and research targets, the manufacturer’s role expands from simple supplier to knowledge partner. We look forward, not only tracking regulations and customer trends but also adapting methods and processes—because animal health, market stability, and customer trust all depend on what happens long before the product reaches its end user.